MEDDU

The main aim of the project is to develop original liposome-based bubbles formulations for safe, non invasive and controllable ultrasound (US) and microbubbles (MB) targeted gene delivery (UMTD). Compared to other physical delivery methods, it allows the possibility to reach deeper organs with a non-invasive manner. Under US activation, MB oscillations near a plasma membrane increase cell permeability attributed to transient pores formation (sonoporation). However, recent data including ours suggest that endocytosis mechanism could also occur. The type of mechanism(s) involved could be both dependent both on the size and on the microbubble chemical composition and on the type of insonified tissue or cells. Our preliminary data from real time experiments showing a better entry of small bubbles under specific acoustic conditions strengthen this hypothesis. Thus, a key to success of this system lies in understanding of mechanisms governing the interactions of MB and cells. This can be addressed by controlling the size of MB and tailoring the chemical composition of the MB to assess their impact on interactions with cell membranes. Compared to available MB, these original bubbles will have specific acoustic properties and surface modifications to increase their interactions and/or fusion with cellular membranes and therefore the delivery of their payload. This project comprises two parts: a fundamental one consisting of smart liposomes bubbles preparation, the study of their acoustic and physicochemical properties, as well as the understanding of all mechanisms governing ultrasound-microbubble-cell interactions; and a second one consisting of their experimental development for in vivo gene delivery. Lipids that will be used are original and have been developed by the partners. They possess specific activities towards cell membranes, especially in terms of pH sensitivity. New bubbles will be characterized by their physico-chemical and acoustic parameters. We will also study internalization and intracellular routing of both MB and their cargo. In the literature, no clear knowledge on intracellular routing of MB is known. For in vivo application, we will investigate the relationship between physicochemical properties of MB and their ability to accumulate in a specific area of the body after systemic administration. Finally, MB will be exploited for gene delivery. Especially, we will focus on their capacity to deliver genes in tendons and liver following local and systemic administration respectively. Undertaking this project will allow us to fine tune MB chemical composition for an efficient ultrasound and microbubbles targeted delivery. Furthermore, our original MB could serve as platforms to develop targeted MB for both imaging and delivery applications in the future.